Effects of β-sitosterol derived from Artemisia capillaris on the activated human hepatic stellate cells and dimethylnitrosamine-induced mouse liver fibrosis

BMC Complementary and Alternative Medicine

Volumn 14, Issue 1, 2014, Pages

  Kim, Ki Suk ^a   Yang, Hea J ^a   Lee, Jae Youl ^a   Na, Yun Cheol ^b   Kwon, Soo Young ^a   Kim, Young Chul ^a   Lee, Jang Hoon ^a   Jang, Hyeung Jin ^a  

^a Kyung Hee University   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

Anti fibrosis; Collagen type 1 (collagen 1); Dimethylnitrosamine (DMN); smooth muscle actin ( SMA); sitosterol

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; DIMETHYLNITROSAMINE; GELATINASE A; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; SITOSTEROL; TRANSFORMING GROWTH FACTOR BETA; ACTIN; GAMMA-SITOSTEROL; PLANT EXTRACT; SITOSTEROL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTEMISIA CAPILLARIS; ARTICLE; CELL ACTIVATION; CELL VIABILITY ASSAY; CONTROLLED STUDY; DIMETHYLNITROSAMINE-INDUCED LIVER FIBROSIS; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MASS FRAGMENTOGRAPHY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STELLATE CELL; UPREGULATION; ANIMAL; ARTEMISIA; C57BL MOUSE; CELL LINE; CELL SURVIVAL; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; GENETICS; LIVER CIRRHOSIS; METABOLISM;

ACTINS; ANIMALS; ARTEMISIA; CELL LINE; CELL SURVIVAL; COLLAGEN TYPE I; DIMETHYLNITROSAMINE; GENE EXPRESSION; HEPATIC STELLATE CELLS; HUMANS; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED C57BL; PLANT EXTRACTS; SITOSTEROLS;

EID: 84907992171     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-363     Document Type: Article

References (29)

1. Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 2003, 37(3):493-503. 10.1053/jhep.2003.50127, 12601343.
2. Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010, 7(8):425-436. 10.1038/nrgastro.2010.97, 20585339.
3. Hillebrandt S, Goos C, Matern S, Lammert F. Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15. Gastroenterology 2002, 123(6):2041-2051. 10.1053/gast.2002.37069, 12454860.
4. Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, Tainturier MH, Myers RP, Muntenau M, Ratziu V, Manns M, Vogel A, Capron F, Chedid A, Bedossa P, . Panfibrosis Group A comparison of fibrosis progression in chronic liver diseases. J Hepatol 2003, 38(3):257-265. 10.1016/S0168-8278(02)00413-0, 12586290, Panfibrosis Group.
5. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biological Chem 2000, 275(4):2247-2250.
6. Hellerbrand C, Stefanovic B, Giordano F, Burchardt ER, Brenner DA. The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo. J Hepatol 1999, 30(1):77-87. 10.1016/S0168-8278(99)80010-5, 9927153.
7. Morrison SJ, White PM, Zock C, Anderson DJ. Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells. Cell 1999, 96(5):737-749. 10.1016/S0092-8674(00)80583-8, 10089888.
8. Xu L, Hui AY, Albanis E, Arthur MJ, O'Byrne SM, Blaner WS, Mukherjee P, Friedman SL, Eng FJ. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 2005, 54(1):142-151. 10.1136/gut.2004.042127, 1774377, 15591520.
9. Gressner OA, Weiskirchen R, Gressner AM. Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options. Comp Hepatol 2007, 6:7. 10.1186/1476-5926-6-7, 1994681, 17663771.
10. Han C-W, Lee J-H. Effects of KHchunggan-tang on the nonalcoholic fatty liver disease in palmitate-induced cellular model. J Korean Oriental Med 2010, 32(1):109-110.
11. Matsuoka K, Nakazawa T, Nakamura A, Honda C, Endo K, Tsukada M. Study of thermodynamic parameters for solubilization of plant sterol and stanol in bile salt micelles. Chem Phys Lipids 2008, 154(2):87-93. 10.1016/j.chemphyslip.2008.05.002, 18544343.
12. Shin M-H, Suh H-W, Lee K-B, Kim K-S, Yang HJ, Choi E-K, Cho YJ, Song M-Y, Ahn KS, Jang H-J. Gentiana scabra extracts stimulate glucagon-like peptide-1 secretion via G protein-coupled receptor pathway. BioChip J 2012, 6(2):114-119.
13. Kim KS, Lim DJ, Yang HJ, Choi EK, Shin MH, Ahn KS, Jung SH, Um JY, Jung HJ, Lee JH, Lee SG, Jung SK, Jang HJ. The multi-targeted effects of Chrysanthemum herb extract against Escherichia coli O157:H7. Phytother Res 2013, 27(9):1398-1406. 10.1002/ptr.4859, 23255247.
14. Kim KS, Yang HJ, Choi EK, Shin MH, Kim KH, Um JY, Lee BC, Jang HJ. The effects of complex herbal medicine composed of cornus fructus, dioscoreae rhizoma, aurantii fructus, and Mori folium in obese type-2 diabetes mice model. Orint Pharm Exp Med 2013, 13:69-75.
15. George J, Rao KR, Stern R, Chandrakasan G. Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen. Toxicology 2001, 156(2-3):129-138.
16. Friedman SL. Stellate cell activation in alcoholic fibrosis-an overview. Alcohol Clin Exp Res 1999, 23(5):904-910.
17. Hautekeete ML, Geerts A. The hepatic stellate (Ito) cell: its role in human liver disease. Virchows Arch 1997, 430(3):195-207. 10.1007/BF01324802, 9099976.
18. Knittel T, Kobold D, Saile B, Grundmann A, Neubauer K, Piscaglia F, Ramadori G. Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 1999, 117(5):1205-1221. 10.1016/S0016-5085(99)70407-5, 10535885.
19. Bachem MG, Meyer D, Melchior R, Sell KM, Gressner AM. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest 1992, 89(1):19-27. 10.1172/JCI115561, 442814, 1729271.
20. Kim E, Park CS, Han T, Bae MH, Chong W, Lee CH, Shin YA, Ahn BN, Kim MK, Shin CY, Son MH, Kim JK, Moon HS, Shim HJ, Kim EJ, Kim SH, Lim JI, Lee CH. Design, synthesis, and evaluation of novel aryl-tetrahydropyridine PPARalpha/gamma dual agonists. Bioorg Med Chem Lett 2008, 18(18):4993-4996. 10.1016/j.bmcl.2008.08.020, 18771917.
21. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci 2002, 7(7):d793-d807.
22. Noetel A, Kwiecinski M, Elfimova N, Huang J, Odenthal M. microRNA are Central players in anti- and profibrotic gene regulation during liver fibrosis. Front Physiol 2012, 3(3):49. 3307137, 22457651.
23. Dienstag JL, Goldin RD, Heathcote EJ, Hann HW, Woessner M, Stephenson SL, Gardner S, Gray DF, Schiff ER. Histological outcome during long-term lamivudine therapy. Gastroenterology 2003, 124(1):105-117. 10.1053/gast.2003.50013, 12512035.
24. Falize L, Guillygomarc'h A, Perrin M, Laine F, Guyader D, Brissot P, Turlin B, Deugnier Y. Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases. Hepatology 2006, 44(2):472-477. 10.1002/hep.21260, 16871557.
25. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008, 88(1):125-172. 10.1152/physrev.00013.2007, 2888531, 18195085.
26. Hammel P, Couvelard A, O'Toole D, Ratouis A, Sauvanet A, Flejou JF, Degott C, Belghiti J, Bernades P, Valla D, Ruszniewski P, Levy P. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 2001, 344(6):418-423. 10.1056/NEJM200102083440604, 11172178.
27. Hong JH, Lee IS. Effects of Artemisia capillaris ethyl acetate fraction on oxidative stress and antioxidant enzyme in high-fat diet induced obese mice. Chem Biol Interact 2009, 179(2-3):88-93.
28. Lee HI, Seo KO, Yun KW, Kim MJ, Lee MK. Comparative study of the hepatoprotective efficacy of Artemisia iwayomogi and Artemisia capillaris on ethanol-administered mice. J Food Sci 2011, 76(9):T207-T211. 10.1111/j.1750-3841.2011.02385.x, 22416729.
29. Wang JH, Choi MK, Shin JW, Hwang SY, Son CG. Antifibrotic effects of Artemisia capillaris and Artemisia iwayomogi in a carbon tetrachloride-induced chronic hepatic fibrosis animal model. J Ethnopharmacol 2012, 140(1):179-185. 10.1016/j.jep.2012.01.007, 22265746.